Carrick Therapeutics, Inc.

The end of each year brings a surge in venture capital funding announcements as biopharmaceutical companies and investors seek to close as many deals as possible before everyone takes off for the Dece

A lot of money flowed through the pharma and biotech M&A space in the third quarter of this year, and while deal volume was similar to the second quarter, the value of those acquisitions shot up, acco

Four new sources of venture capital for biotechnology companies were announced during the first half of May with more than $1.7bn in fresh funding for start-ups and growing early-stage firms. Abingwor

The Biotechnology Innovation Organization (BIO) has submitted comments to the US Department of the Treasury about proposed foreign investment regulations that the trade group believes will prevent for